Digest Network How does it work
Network
/
Society
Ha
Not verified

Hansa Biopharma AB

What we write about

BiologyEconomicsImpresePharmaceuticalsSanità

18 Press releases

View all press releases
24/04/2025
Pharmaceuticals
Sanità
Imprese
Biology
Hansa Biopharma Reports First Quarter and Interim January-March 2025 Financial Results
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
21/03/2025
Pharmaceuticals
Sanità
Economics
Biology
Hansa Biopharma publishes 2024 Annual and Sustainability Reports
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
11/03/2025
Pharmaceuticals
Sanità
Hansa Biopharma completes enrolment in European Phase 3 20-HMedIdeS-19 Post Authorization Efficacy and Safety study in highly sensitized kidney transplant patients
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
06/02/2025
Pharmaceuticals
Sanità
Imprese
Biology
Hansa Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
07/01/2025
Pharmaceuticals
Sanità
Biology
Hansa Biopharma to attend 2025 J.P. Morgan Healthcare Conference
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
17/12/2024
Pharmaceuticals
Sanità
Biology
Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 study and comparative analysis of imlifidase in patients with Guillain-Barré Syndrome
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
05/12/2024
Pharmaceuticals
Sanità
Economics
Start-up
Biology
Hansa Biopharma Completes Enrolment in Global Pivotal Phase 3 Trial of imlifidase in Anti-Glomerular Basement Membrane Disease
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
03/12/2024
Pharmaceuticals
Sanità
Economics
Start-up
Biology
Genethon and Hansa Biopharma announce initiation of a Phase 2 trial of imlifidase as a pre-treatment to GNT-0003 in severe Crigler-Najjar syndrome
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
30/10/2024
Pharmaceuticals
Sanità
Media
Communication
Multimedia
Electronic publishing
Finance
Biology
Hansa Biopharma to Attend Truist Securities BioPharma Symposium
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0
17/10/2024
Pharmaceuticals
Sanità
Economics
Imprese
Biology
Hansa Biopharma Reports Third Quarter and Interim January - September 2024 Financial Results
Source
Hansa Biopharma AB
Issuer
PR News Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0